That same body of work fed into an early-phase human trial registration (NCT02637284) that was later withdrawn before results were reported, which is why anyone telling you BPC-157 is "clinically proven" in humans is overstating the record
Be cautious with guaranteed results, permanent-lightening claims, pressure to buy a series before an assessment, or reluctance to discuss risks
For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
Yu J, Diao X, Zhang X, Chen X, Hao X, Li W, et al
The wolverine stack is a combination of two prescription peptides, BPC-157 and TB-500, used together to support tissue repair and recovery
Research data: GHK-Cu benefits from a solid body of research, including clinical data in humans (topical application)